The Role of Hypoxia-Inducible Factor Stabilizers in the Treatment of Anemia in Patients With Chronic Kidney Disease

Drug Design, Development and Therapy - New Zealand
doi 10.2147/dddt.s175887
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors: A Potential New Treatment for Anemia in Patients With CKD

American Journal of Kidney Diseases
Nephrology
2017English

Anemia Treatment With Q2W Darbepoetin Alfa in Patients With Chronic Kidney Disease Naïve to Erythropoiesis-Stimulating Agents

Current Medical Research and Opinion
Medicine
2008English

Renal Anaemia: The Role of Haemoglobin Control in Patients With Chronic Kidney Disease

Proceedings of the Latvian Academy of Sciences, Section B: Natural, Exact, and Applied Sciences
Multidisciplinary
2010English

Hypoxia-Inducible Factor 1 (HIF-1) as a Biomarker of Acute Kidney Injury in Patients With Acute Decompensation of Chronic Heart Failure

Kardiologiya
Cardiovascular MedicineCardiology
2019English

Involvement of Hypoxia-Inducible Transcription Factors in Polycystic Kidney Disease

American Journal of Pathology
Forensic MedicinePathology
2007English

MicroRNA-186 Is Associated With Hypoxia-Inducible Factor-1α Expression in Chronic Obstructive Pulmonary Disease

Molecular genetics & genomic medicine
GeneticsMolecular Biology
2018English

The Use of Metformin in Patients With Chronic Kidney Disease

Annales Academiae Medicae Silesiensis
2017English

Pharmacoeconomic Analysis of Сosmofer (Iron III - Hydroxide Dextran) in the Treatment of Iron Deficiency Anemia for Chronic Kidney Disease Patients

Pharmacoeconomics: theory and practice
2017English

Increased Expression of Hypoxia-Inducible Factor 1α in Coeliac Disease

Pediatric Research
Child HealthPediatricsPerinatology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy